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REVIEW OF THE LITERATURE 
1. Introduction 
Membranes, composed of lipids and proteins, play a key role in the structure and 
function of the eukaryotic cell. Plasma membrane forms a barrier between the outside 
environment and the inside of the cell. It functions as a control point for uptake of 
different ions and nutrients and passes the external signals into the intracellular space. 
Membranes make up the structure of different organelles, they separate intracellular 
compartments from each other and they form the routes for rapid delivery of different 
compounds to various cellular locations. 
Membrane bilayers are composed of complex arrays of lipids and proteins. 
The main groups of lipids in mammalian membranes are glycerolipids, sphingolipids 
and cholesterol. Proteins are either integrated into the membrane bilayer or are 
peripherally associated with membranes, where they interact with headgroups of 
lipids and/or other peripheral or integral proteins. Membrane rigidity can be regulated 
by the lipid composition of the membrane; here the fatty acid composition of lipids 
and the amount of cholesterol in the bilayer are important factors. Membranes also 
contain different laterally organized domains that consist of specific lipids and 
proteins with distinct characteristics. 
For decades a great deal of research has focused on cholesterol. Cholesterol is 
an important membrane component, however it can be harmful physiologically when 
an excess amount is obtained from the diet. Over time, excess cholesterol accumulates 
in the arterial intima and causes the formation of fatty streaks that finally leads to the 
disease state, atherosclerosis.  
Oxygenated derivatives of cholesterol, oxysterols, are suggested to be 
involved in many biological processes such as cholesterol turnover, atherosclerosis, 
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apoptosis, inflammation, immunosuppression and the development of gallstones. 
Oxysterols are known to affect the expression of several critical enzymes in 
cholesterol biosynthesis, the receptor-mediated uptake of cholesterol, and other 
aspects of cellular cholesterol homeostasis. Furthermore, they are potent regulators of 
catabolism of cholesterol to bile acids. 
 
In this thesis I will describe the recently identified (I, II) human oxysterol-binding 
protein (OSBP)-related protein (ORP) family and characterize one family member 
named ORP2 and its effects on cellular lipid metabolism (III, IV). 
 
2. Composition of biological membranes 
2.1 The major lipid classes and their distribution within the cell 
One important feature of membranes is the asymmetric distribution of lipids between 
the two leaflets of the bilayer which is actively maintained by specific proteins (Sims 
and Wiedmer, 2001). Another feature is the unequal distribution of different lipids 
and proteins between various intracellular membranes. All lipid classes, sphingolipids 
(SLs), glycerolipids (GLs) and sterols (cholesterol in mammals) have distinct 
intracellular distributions between different cellular membranes and within a single 
membrane. The structure and the membrane orientation of three lipids studied in this 
thesis work: cholesterol, sphingomyelin (SM) and phosphatidylcholine (PC) is 
illustrated in Figure 1. 
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Phospholipids (PLs) the most abundant of which are phosphatidylcholine 
(PC), phosphatidylethanolamine (PE), sphingomyelin (SM), phosphatidylserine (PS), 
phosphatidylinositol (PI) and phosphatidic acid (PA) comprise 80% of all membrane 
lipids. Their intracellular distributions and functions in cells are largely different. PC 
is widely spread throughout the cell, while SM and cholesterol are enriched in the 
plasma membrane (PM) and endosomes (Lange et al., 1989; Slotte et al., 1989; 
Warnock et al., 1993). In epithelial cells, the apical PM contains more SM compared 
to the basolateral membrane. Different PL species are asymmetrically distributed in 
the PM so that most of the PC and SM are found in the outer leaflet and that most of 
the PE and PS are found in the inner leaflet (Devaux, 1992; Vance, 1996). One can 
speculate that the shape of a lipid molecule, like in the case of PE, favors its location 
in the inner leaflet. PE is a cone shaped molecule and its shape can be postulated to 
prefer curved rather than planar membranes. Localization of PE in the inner leaflet 
would then shape the PM. This could also be important in vesicle trafficking, as it 
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would provide a driving force in membrane bending (Devaux, 1992; Sims and 
Wiedmer, 2001). The head group of PS has a negative charge and this could enhance 
the interaction of Ca2+ ions with the membrane and cytoskeletal elements (Sims and 
Wiedmer, 2001) as well as with specific enzymes such as protein kinase C (Devaux, 
1992; Ochoa et al., 2002). In addition, glycerophospholipids are precursors of many 
bioactive lipids. For example, PC is hydrolysed to PA and choline by phospholipase 
D and can also be hydrolyzed to arachinoic acid and lyso-PC by phospholipase A2 
(PLA2) (Funk, 2001; Ohanian and Ohanian, 2001; Wakelam et al., 1997). 
Sphingolipids are found in all eukaryotic cells. They are enriched in the PM, 
Golgi and endosomal membranes and their metabolites are involved in many cellular 
processes including differentiation, senescence, apoptosis and proliferation (Ohanian 
and Ohanian, 2001). Glycosphingolipids are found predominantly in the outer leaflet 
of the PM and in the lumenal leaflet of intracellular vesicles and in organelles 
involved in membrane trafficking. Together with the glycoproteins they mediate 
intercellular interactions, cell to cell communication and have diverse functions in the 
immune system (Holthuis et al., 2001; Vance, 1996). Sphingolipids are, like 
glycerolipids, precursors of various intracellular signaling molecules such as 
sphinganine, sphingosine-1-phosphate and ceramide (Pyne and Pyne, 2000; Ruvolo, 
2001; Venkataraman and Futerman, 2000). In polarized cells, sphingolipids are 
preferentially localized to the apical membrane. Domains rich in sphingolipids and 
cholesterol are suggested to mediate trafficking to the apical membrane (Maier et al., 
2001). 
Only a small amount of the cellular cholesterol is found within the ER where it is 
synthesized and the concentration of cholesterol increases in the membranes along the 
secretion route towards the PM. For normal cellular processes to function it is 
essential that the cholesterol concentration in membranes remains under tight control. 
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This is due to the strong influence of cholesterol on the structure and function of 
membranes. Cholesterol interacts with the fatty acyl chains of glycerolipids and 
sphingolipids but it has been shown to prefer the sphingoid base moiety and thus to 
associate instead with sphingolipids rather than with glycerolipids (Ridgway, 2000). 
Together with SM and glycosphingolipids cholesterol forms active membrane 
domains designated as either detergent-resistant membranes (DMRs) or rafts (Simons 
and Ikonen, 2000). Despite this fact one must not forget that a significant portion of 
cholesterol is also found in non-raft membranes. The concept of membrane domains 
will be discussed in the following chapters. Another important function of cholesterol 
is to regulate the rigidity and permeability of the lipid bilayer. By reducing the 
leakage of ions through the lipid bilayer, cholestrol acts as a barrier and thereby 
facilitates sustained membrane function (Haines, 2001). The molar ratio of 
phospholipids to free cholesterol (PL/FC) is important for determining membrane 
viscosity. For example, the PL/FC ratio within the ER and mitochondria is low as 
compared to the PM and this results in lowered rigidity and increased permeability of 
the intracellular membranes. 
 
2.2 Intracellular transport of lipids 
The transport of membrane lipids within a lipid bilayer occurs laterally, however they 
can also switch sides from the cytosolic to the outer/lumenal leaflet or vice versa. 
Furthermore lipids are constantly transported between different membranes and 
organelles, especially when they are synthesized or taken up by the cells. In both 
cases lipids have to be transported to the site where they are needed. Many of the 
enzymes involved in phospholipid and cholesterol synthesis are located in the ER and 
especially at the cytosolic side of the ER membrane. Therefore when synthesis is 
complete, lipids must somehow translocate to the lumenal side of the bilayer. The 
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protein factors that facilitate this translocation in the ER remain unknown. What is 
known, however, are the proteins involved in the translocation of PM phospholipids, 
such as the P-glycoproteins encoded by the MDR3 (also known as MDR2) genes 
(Borst et al., 2000). 
The lateral and transbilayer movement of lipids occurs spontaneously. A 
single lipid can also spontaneously diffuse between different membranes, however, 
experimental data suggests that this is a very slow process. As lipids are hydrophobic 
compounds, special transport proteins or other mechanisms are required to move them 
through the hydrophilic environment. It is well established that vesicles transport both 
membrane bound and secreted proteins and it is possible that lipids use the same or 
similar routes. Transfer of lipids between different membranes may also occur via 
fusion or hemifusion of membrane bilayers (Vance, 1996). 
Specialized detergent resistant membrane (DRM) domains, rafts, are 
suggested to have a role in both lipid and protein trafficking. These sphingolipid and 
cholesterol rich microdomains are apparently involved in the sorting of cargo and the 
formation of vesicles. In addition to this, more and more evidence supports their role 
in endocytosis and signaling events (Ikonen and Parton, 2000). In mammals, rafts are 
formed in the Golgi complex (Simons and Ehehalt, 2002) however in yeast they are 
already formed in ER membranes (Bagnat et al., 2000; Dickson and Lester, 2002). 
Rafts may be involved in the transport and recycling of newly synthesized free 
cholesterol between the TGN, endosomes and the PM (Mukherjee and Maxfield, 
2000; Simons and Ehehalt, 2002). There are proteins, especially caveolins, typically 
enriched in lipid rafts (Fielding and Fielding, 2001a; Zajchowski and Robbins, 2002). 
Rafts do not necessarily contain marker proteins, instead these membrane domains 
can arise solely through interactions between lipids (Anderson and Jacobson, 2002).  
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ABC transporters are a family of proteins whose members are known to 
function as lipid transporters. One family member, ABCA1 is known to be essential 
for cholesterol efflux and has also been implicated in the transport of cholesterol via 
the secretory pathway (Borst et al., 2000). Another ABC transporter, ABCB1 is 
known to transport cholesterol from the PM to the ER (Schmitz and Kaminski, 2001). 
In addition, members from ABCG, the white subfamily of the ABC transporters, are 
also involved in cholesterol trafficking (Schmitz et al., 2001). Another type of lipid 
transporter, NPC (Niemann-Pick C) protein regulates the transport of LDL-derived 
cholesterol from lysosomal compartments to other parts in the cell, however, the 
precise function of this protein is still largely unknown. A dramatic neurovisceral 
lipid storage disorder, called Niemann-Pick type C disease, arises from genetic 
defects in the NPC protein (Garver and Heidenreich, 2002). Transport of cholesterol 
to the inner mitochondrial membrane is mediated by StAR (steroidogenic acute 
regulatory protein), which is required for steroid hormone synthesis in specific tissues 
(Christenson and Strauss, 2000; Christenson and Strauss, 2001). StAR-related lipid 
transfer (START) domains also exist in other proteins that are involved in lipid 
transport and metabolism like PC transfer protein (PC-TP), MLN64 and a putative 
acyl-CoA thioesterase (Tsujishita and Hurley, 2000).   
Intracellular phospholipid transport, translocation, efflux and uptake are all 
processes that are connected to each other and to the transport of cholesterol/other 
lipids (Kent and Carman, 1999; Ridgway, 2000). This provides strict control over 
lipid homeostasis in the cell. In addition to feedback type regulatory mechanisms of 
lipid biosynthetic enzymes, lipid transport is also an important way to regulate the 
distribution and overall homeostasis of lipids. 
The phosphatidylinositol transfer protein (PITP) family in mammals consists 
of two proteins; PITPα and PITPβ, which share 77% identity. They are known to bind 
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and transfer PI and PC, and PITPβ is also known to transfer SM (Segui et al., 2002). 
In yeast, Sec 14p is an important PITP protein involved in Golgi vesicle transport. It 
is postulated that Sec14p is needed for scission of COPI coated vesicles from the 
Golgi membrane (Simon et al., 1998). 
Fatty acid (FA) transport is important for the synthesis of membrane lipids and the 
intracellular messengers derived from them. Furthermore, unsaturated FAs are the 
precursors for leukotrienes, prostaglandins and tromboxanes and they are needed for 
energy production (Eaton, 2002; Hettema and Tabak, 2000). In eukaryotic 
membranes, long-chain FAs (LCFAs) are taken up as LCFA/albumin complexes and 
their transport within cells is facilitated by specific proteins (Schaffer, 2002). There 
are a number of known proteins which putatively bind and transport fatty acids in 
cells, and they can be divided into three main types (Eaton, 2002): plasma membrane 
FA binding proteins (FABPpm) (Stremmel et al., 1985), FA translocase (FAT/CD36) 
(Harmon et al., 1991), and FA transport proteins (Abumrad et al., 1999).  
 
3. Intracellular membrane trafficking 
3.1 The intracellular trafficking pathways 
There are two main membrane trafficking routes in cells: The secretory or 
biosynthetic pathway is one in which membrane bound or secreted proteins and many 
of the lipids travel from the ER to either the PM or to various cellular organelles. The 
other is the endocytic pathway, which is responsible for the uptake of various 
compounds from the extracellular milieu (Mellman and Warren, 2000; Olkkonen and 
Ikonen, 2000). 
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Membrane bound proteins or proteins that are destined for secretion typically 
contain a signal sequence that targets the translated protein to the rough ER 
translocation machinery (Mellman and Warren, 2000). The signal sequence can be 
cleaved as is the case for most secreted or lumenal proteins or otherwise the signal 
sequence can anchor the protein to the membrane. Proteins may contain many 
different signal sequences, and these determine membrane topology and the 
destination of the protein in cellular compartments (Vance, 1996). After translocation, 
proteins fold in the ER and glycoproteins acquire sugar moieties. They are then 
transported from the ER to the Golgi complex (cis-, medial - and trans -Golgi) and 
then to the major protein sorting station of the cell, the trans-Golgi-network (TGN) 
(Gu et al., 2001).  
In the endocytic pathway vesicles are targeted to their intracellular 
localization, first to early endosomes from which cargo molecules then move to late 
endosomes and finally to lysosomes for degradation. The receptors are either recycled 
back to the PM or degraded. In the endocytic pathway receptors and components of 
the transport machinery are recycled back to the PM following the release of cargo 
from the vesicle to the target organelle (Mellman and Warren, 2000). To date most of 
the studies on endocytosis have focused on the clathrin-mediated pathway (Takei and 
Haucke, 2001). In addition to this route there are several different endocytic routes 
that are clathrin-independent (Nichols and Lippincott-Schwartz, 2001). 
Secretion and endocytosis are connected at the level of the TGN and early and 
late endocytic organelles.  In the next chapter, 3.2, the machinery of both the secretory 
and the endocytotic route are described. 
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3.2 Trafficking machinery 
All of the steps involved in the vesicle trafficking in the secretory pathway require the 
fine tuned interaction of cargo molecules, membrane proteins, cytosolic coat proteins 
and cytoskeletal elements. All of these components are essential for vesicle budding 
from the ER, docking and fusing to cis Golgi membranes, vesicle traffic between the 
Golgi membranes, to the TGN and finally to the PM (Aridor et al., 1999; Barlowe et 
al., 1994; Scales et al., 2000). Coat proteins are needed for vesicles to bud. COPII is 
required for exit from the ER, COPI in both retro- and anterograde transport between 
the ER and the Golgi, in the intra-Golgi transport and endosomes. Clathrin mediates 
in transport routes of the endosomal pathway.  The specific adaptor proteins, AP-1, -
2, -3 and –4, are needed in the endocytic route including also the transport between 
endosomal organelles and the TGN (Kreis et al., 1995; Takai et al., 2001). Small 
GTPases of the ARF (ADP-ribosylation factor) family are considered important for 
vesicular transport, especially along the secretory and endocytic pathways (Takai et 
al., 2001). Arf1 and another small GTPase, Sar1, are postulated to have a function in 
the budding of transport vesicles from the ER and Golgi membranes (Takai et al., 
2001; Ward et al., 2001). Transmembrane receptors can bind to either soluble or 
membrane bound ligands and interact with cytosolic coat protein complexes. Small 
GTPases are needed not only for assembly of the coat complex and budding of the 
vesicle, but also for targeting transport vesicles to the correct acceptor compartment. 
The largest family of small GTPases is the family of Rab proteins. Over 50 members 
of this family have been isolated in mammals. These proteins function in transport 
vesicle formation, vesicle movement along the cytoskeletal elements and especially in 
the specific tethering of vesicles at the target compartments (Pfeffer, 2001; Smythe, 
2002; Zerial and McBride, 2001). 
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For vesicle targeting in the secretory and endocytic pathways, another organelle-
specific family of proteins is required. After vesicles are tethered at the acceptor 
compartment, a more intimate docking and fusion of membranes occurs. This process 
is mediated by proteins called SNARE (soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor) proteins. There are 36 known mammalian SNARE 
proteins and many of them have corresponding yeast homologues. For fusion to 
occur, vesicle SNAREs (v-SNAREs) and the target membrane SNAREs (t-SNAREs) 
interact. Four α-helixes from v-and t-SNAREs interact to form a coiled coil structure, 
which is thought to bring membranes of the vesicle and of the target close to each 
other to facilitate fusion. The exact mechanism of how the fusion pore finally evolves 
is still under discussion (Bruns and Jahn, 2002; Hay, 2001; Hepp and Langley, 2001). 
 
3.3 The role of membrane lipids in vesicle transport 
Vesicle transport of proteins is relatively well characterized, however, the importance 
of lipids is only beginning to emerge. The lipid composition of vesicles is controlled 
by lipid modifying enzymes. In the secretory pathway, formation of vesicles in the ER 
requires the action of phospholipase D (PLD) (Wakelam et al., 1997) to cleave off the 
polar head group of PC and thereby to produce PA (Howe and McMaster, 2001). The 
COPI dependent Golgi to ER recycling pathway is stimulated by PA and PtdIns(3,4)-
bisphosphate and possibly inhibited by diacylglycerol (DAG) (Roth, 1999). In 
constitutive secretion, PLD plays the important role of stimulating the production of 
PtdIns(3,4)-bisphosphate, which is required for vesicle formation (Simonsen et al., 
2001). Formation of some Golgi derived vesicle populations appears to require 
PtdIns(3)-phosphate, and PtdIns(3,4,5)-triphosphate is suggested to  stimulate  the 
nucleotide exchange of ARF during regulated secretion. In addition to the enzymes 
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that modify polar head groups of lipids, other enzymes that modify the FA 
composition of membrane lipids have an effect on vesicle transport. Acyltransferases 
like endophilins (Huttner and Schmidt, 2000) and BARS (Weigert et al., 1999) play a 
role in modifying the FA moieties of lipids. This results in changes in the shape of 
lipid molecules, which is also important for vesicle transport. 
Phosphoinositides, DAG and PA are believed to be important during different 
secretory and endocytotic steps (Goni and Alonso, 1999; Takenawa and Itoh, 2001). 
Phosphoinositides are formed in response to PA production (by PLD) (Roth, 1999). In 
clathrin-dependent endocytosis several proteins (like AP-2) bind to PI(4,5)P2. 
Association of other proteins with AP-2 initiates assembly of components of the 
vesicle membranes into clathrin-coated pits. Additional proteins are then required for 
invagination and scission of the clathrin-coated pits (Takenawa and Itoh, 2001). 
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4. Fundamental mechanisms responsible for cellular cholesterol 
homeostasis 
 
Cellular cholesterol exists in two forms. Free cholesterol is the form found in 
membranes and cholesterol esters are found in cytosolic droplets as a cholesterol 
reservoir. To maintain cellular cholesterol balance, cells can make cholesterol by de 
novo synthesis or obtain cholesterol from the external enviroment. When there is an 
excess of cholesterol inside the cell, the cholesterol can be effluxed to extracellular 
acceptors or stored as cholesterol esters. Cholesterol is synthesized in the ER, but only 
a small fraction of the total cellular cholesterol is found in the ER membranes. Part of 
the cholesterol is transported via the Golgi complex and TGN to the PM where the 
major fraction of cellular cholesterol is located. The major pathway of cholesterol 
transport seems to bypass the Golgi. The transport mechanism behind the Golgi 
bypass route is still under investigation (Simons and Ikonen, 2000). An overview of 
cellular cholesterol processing and trafficking is given in Figure 2. The way 
cholesterol is metabolized depends largely on the cell type. In the liver, in adipose 
tissue, in macrophages or in steroidogenic tissue cholesterol is used for very different 
purposes.  
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Figure 2. Cellular cholesterol processing and trafficking.  
Cholesterol is synthesized in the ER and transported partly via the Golgi complex (1) and 
TGN to the PM. In the PM cholesterol is distributed between raft (black boxes in the 
membranes) and non-raft microdomains. This can happen already in the Golgi or TGN. A 
majority of cholesterol, however, bypasses the Golgi and is transported via yet unknown 
pathway to the PM (2). Cholesterol can be internalized back from the PM via endosytosis 
using either clathrin-coated vesicles or other vesicles, such as those containing caveolin (8). 
Cholesterol can then be recycled back to the PM (9) or to the ER (10). Cholesterol can be 
taken up from the external milieu via receptor mediated uptake of LDL particles (4). LDL is 
endocytosed via clathrin-coated pits and cholesterol is transported to sorting endosomes (SE). 
From there, cholesterol can be recycled back to the PM either directly or via recycling 
endosomes (RE). The internalized cholesterol is transported to late endosomal compartments 
(LE) and to lysosomes. In endocytic organelles, cholesterol esters are hydrolyzed by 
cholesterol ester hydrolases (CEHs) and the free cholesterol is transported to the ER. In the 
ER, free cholesterol produced de novo or taken up by the cells is esterified by the enzyme 
acyl-coenzyme A:cholesterol acyl-transferase (ACAT) to produce cholesterol esters (5). 
Cholesterol esters are then stored as lipid droplets in the cytosol, however, the cholesterol can 
again be mobilized by hydrolysis (6). Direct cholesterol exchange can also occur between 
circulating lipoproteins and the PM. Caveolae have been implicated in the uptake of HDL-
derived cholesterol esters (7) and free cholesterol can be taken up from LDL particles. SR-B1 
is involved in cholesterol ester uptake from HDL particles (11). During active cholesterol 
efflux, lipids are removed via the ABCA1 mediated pathway to lipid -poor apoA-I from which 
nascent HDL particles form (3). Cholesterol can be released from cells both from raft or non-
raft domains. 
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4.1 Receptor mediated cholesterol uptake 
Cholesterol can be endocytosed from the PM via clathrin-coated vesicles or other 
types of vesicles such as caveolae. Cholesterol-sphingolipid rafts are found in the PM 
and in sorting and recycling endosomes. From endosomes, cholesterol can be 
transported either to the Golgi and then to the ER or recycled to the PM (Fielding and 
Fielding, 2000; Fielding and Fielding, 2001a). The LDL receptor pathway is the best-
described route of cholesterol uptake. LDL particles are internalized together with the 
receptor in clathrin-coated pits and then transported to sorting endosomes. The 
receptors recycle to the PM and LDL particles are transported to lysosomes where 
cholesterol esters are hydrolyzed to free cholesterol by cholesterolester hydrolases, 
CEH (Belkner et al., 2000; Kraemer et al., 2002).  
 
4.2 Cholesterol esterification 
Esterification of free cholesterol is accomplished by acyl-CoA cholesterol 
acyltransferase (ACAT), which resides in the ER. Free cholesterol is a component of 
membranes and when an excess amount of cholesterol is produced or internalized by 
the cell it can be esterified and stored as lipid droplets (Chang et al., 2001). In 
macrophages, this accumulation of lipid droplets leads to the formation of ‘foam 
cells’ that are found in atherosclerotic lesions during the early stages of the disease 
(Kruth et al., 2002). On the other hand, in hepatocytes, CE can be incorporated in 
apolipoprotein B (apoB)-containing lipoproteins and secreted (Buhman et al., 2000). 
There are two closely related variants of ACAT; ACAT1 and ACAT2. They are 
differentially expressed as ACAT1 is more ubiquitous and ACAT2 is tissue-specific 
and expressed mainly in the liver and intestine. Interestingly in the liver, ACAT2 is 
localized to hepatocytes whereas ACAT1 is expressed by Kupffer cells (Lee et al., 
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2000). The active sites of the two proteins seem to localize to the opposite sides of the 
ER membrane with ACAT1 positioning at the cytosolic side and ACAT2 at the 
lumenal side. This may indicate their different functions in cellular cholesterol 
esterification (Joyce et al., 2000). 
 
4.3 Cholesterol efflux 
Cholesterol is constantly effluxed from cells by desorption to circulating lipoproteins. 
This type of efflux is often denoted as diffusion-mediated or passive. High-density 
lipoproteins (HDL) are protective against atherosclerosis as they play a major role in 
cholesterol efflux from specific cell types such as macrophages An active, apoA-I 
mediated efflux, is dependent on ABCA1. This protein could promote cholesterol 
translocation from the cytosolic leaflet to the outer leaflet of the PM (Mendez et al., 
2001). Interestingly, SR-B1 is postulated to have a role in bidirectional flux of 
cholesterol between cells and lipoproteins. Overexpression of this protein enhances 
the efflux of cholesterol from macrophages to lipoproteins, specifically to HDL, and 
alters the steady state level of both cholesterol and phospholipids in these cells (de la 
Llera-Moya et al., 1999; Yokoyama, 2000). In the liver, cholesterol from peripheral 
tissues can be taken up by the receptor mediated pathway or by the SR-B1 pathway 
(Krieger, 2001). The liver and intestine secrete cholesterol in the form of esters that 
are complexed with lipoproteins. Another mechanism of cholesterol secretion is also 
postulated where PM vesicles, possibly enriched with raft lipids are released (Simons 
and Ikonen, 2000). 
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4.4 Conversion of cholesterol to bile acids 
An important route by which cholesterol is removed from the body is through its 
catabolism into bile acids by hepatocytes. Bile acids can then be excreted into the 
lumenal space of the intestine via the gallbladder. The production of bile acids is 
considered a part of the reverse cholesterol transport process as the cholesterol that is 
effluxed from peripheral cells is taken from the circulation by the liver and converted 
into bile acids for excretion (Nofer et al., 2002). The regulation of this process will be 
discussed in chapter 6.2. 
 
4.5 Cholesterol synthesis 
The role of sterol regulatory element-binding proteins (SREBPs) is to regulate the 
genes of cholesterol synthesis and uptake, and fatty acid synthesis. SREBPs are 
transcription factors, and the repertoire of their target genes is constantly expanding 
(Shimano, 2001). SREBPs are localized to ER membranes and are inactive when they 
are in the full-length membrane bound form. The N-terminal portion of the protein 
contains the activator and is proteolytically cleaved by site-1 and site-2 proteases in 
the Golgi. SREBP cleavage activating protein (SCAP) is needed for this cleavage 
process. When sterol is depleted SCAP undergoes conformational changes and 
SCAP/SREBP complex is then targeted to the Golgi for the two-step cleavage. After 
cleavage, SREBP is transported to the nucleus by importin β (Brown et al., 2002; 
Nagoshi et al., 1999) and SCAP is recycled back to the ER. The sterol sensing process 
that activates SCAP is still under intense study and is not yet solved. In the nucleus, 
SREBP binds to specific sequences denoted as sterol-regulatory elements (SREs) or 
E-boxes present in a number of promotors. There are three isoforms; SREBP-1a, -1c 
and –2 that are identified to date. SREBP-1a and –1c are products of the same gene 
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and arise through the use of alternate promotors, whilst a separate gene encodes 
SREBP-2. The three isoforms have specialized roles in lipid metabolism. SREBP-1 is 
more likely involved in fatty acid and glucose/insulin metabolism, whereas SREBP-2 
plays an important role in the regulation of cholesterol synthesis and uptake 
(Shimano, 2001). 
The regulation of the SREBP-1c gene is interesting. The promoter contains both a 
SRE element for mature SREBP and a LXR element for the liver X receptor/retinoid 
acid receptor (LXR/RXR) heterodimer to bind. When oxysterols are present they 
inhibit maturation of SREBP and no activation of SREBP-1c takes place. On the other 
hand, oxysterols activate LXR/RXR and binding of this complex to the LXR element 
in the promoter region activates the gene. This LXR/RXR activation of SREBP-1c 
seems to form a link between fatty acid and cholesterol metabolism (Repa et al., 
2000a; Yoshikawa et al., 2001). 
LXRs are cholesterol sensors that regulate many genes responsible for lipid 
homeostasis (Lu et al., 2001). They are expressed in many tissues. LXRα is expressed 
in tissues associated with lipid metabolism such as adipose tissue, kidney, intestine, 
macrophages, lung and adrenals. LXRβ seems to be ubiquitously expressed (Lu et al., 
2001). LXRs are activated by naturally occurring oxysterols including 22R-
hydroxycholesterol, 24S-hydroxycholesterol, 24S,25-epoxycholesterol and 27-
hydroxycholesterol. Regulation of cholesterol homeostasis by LXR/RXR has become 
increasingly central in the field because these nuclear receptors are not only regulators 
of the SREBP pathway, but control the expression of a multitude of key genes 
involved in different aspects of cholesterol metabolism, including ABCA1, ABCG1, 
ABCG4, ABCG5 and ABCG8 (Repa et al., 2000b) and apoE, LPL, CETP (Chawla et 
al., 2001; Edwards et al., 2002; Landis et al., 2002). In the liver, the regulation of bile 
acid synthesis through the classical Cyp7a pathway is mediated by LXRα, FXR and 
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SREBP. When oxysterols are available LXRα upregulates Cyp7a transcription and at 
the same time oxysterols suppress the de novo synthesis of cholesterol via SREBP. 
Bile acids suppress Cyp7a transcription and enhance the transport and intestinal 
absorption of bile acids via their interaction with FXR (Davis et al., 2002; Russell, 
1999). 
 
5. Connections between cholesterol and phospholipid metabolism 
 
Stoichiometric ratios of different membrane lipids are tightly regulated. When this 
equilibrium is altered, the cells try to adapt so that the ratios between these lipid 
components remain constant (Ridgway et al., 1999). The mechanisms behind the 
regulation of cellular phospholipid and cholesterol metabolism seem to be 
interconnected (Ohvo-Rekilä et al., 2002; Ridgway, 2000). When the PM is depleted 
of SM, biosynthesis of cholesterol is decreased and its esterification is increased. On 
the other hand, alterations in cellular cholesterol content may not be equally reflected 
in SM metabolism (Ridgway, 2000). However, J.P. Slotte and co-workers reported, 
using cultured human fibroblasts, that when cholesterol is depleted from the PM by 
cyclodextrin or by apoA-I containing POPC vesicles, the synthesis of SM is increased 
and the transport of newly synthesized SM is inhibited (Leppimäki et al., 1998; Ohvo-
Rekilä et al., 2002). Also, addition of sterols to cultured fibroblasts induced 
upregulation of PC synthesis (Leppimäki et al., 2000). The well-described regulator of 
cholesterol biosynthesis, SREBP (see chapter 4.5), also regulates FA synthesis and in 
this way affects PL synthesis (Shimano, 2001). Furthermore, the rate limiting enzyme 
in PC biosynthesis, CTP:phosphocholine cytidylyltransferase (Kent, 1997), is subject 
to SREBP regulation (Kast et al., 2001).   
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6. Oxysterols 
6.1 Structure 
 
Oxysterols are 27-carbon oxygenated derivatives of cholesterol. The nomenclature 
describes the chemical bondage and active group attached and the number describes 
the target carbon in the cholesterol backbone. Cholesterol may be oxygenated mainly 
by hydroxylation, epoxylation or peroxylation. Oxysterols may be formed by 
autooxidation, by enzymatic activation by monooxygenases, or by lipid peroxidation 
(Björkhem and Diczfalusy, 2002). Structures of some important oxysterols are 
depicted in Figure 3. 
 
6.2 Biological functions of oxysterols 
Oxysterols are biologically active derivatives of cholesterol and have regulatory roles 
in a variety of cellular processes, such as in the formation of bile acids, cholesterol 
biosynthesis, uptake and efflux. They also have cytotoxic effects with suggested roles 
in several pathological processes (Brown and Jessup, 1999; Goldstein and Brown, 
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A. Enzymatically oxygenated oxysterols
B. Products of autooxidation
Figure 3. Examples of biologically important oxysterols. A. The most abundant
oxysterols in the circulation B. Important autooxidation products of cholesterol found in
LDL and in foam cells/plaques in the arterial wall.
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1990; Janowski et al., 1996; Repa et al., 2000b; Smith, 1996) (Figure 3). An important 
feature of oxysterols is their ability to pass membranes much faster than cholesterol. 
Together with the fact that after oxidation the half-life of the molecule diminishes, 
oxysterols are useful means of secreting excess sterol. Oxysterols have a number of 
biological roles, in particular the regulation of cholesterol homeostasis by affecting 
the synthesis and catabolism of cholesterol to bile acids. Oxysterols are also 
postulated to have important roles in atherosclerosis, the formation of gallstones, 
inflammation, immunosupression, apoptosis and necrosis (Björkhem and Diczfalusy, 
2002; Brown and Jessup, 1999; O'Callaghan et al., 2002; Panini and Sinensky, 2001; 
Vaya et al., 2001). 
Oxysterols are intermediates in cholesterol excretion pathways and 
quantitatively the most important oxysterols are those involved in bile acid formation. 
Classical starting points in bile acid synthesis are the cholesterol hydroxylation 
products 7α-hydroxycholesterol and 27α-hydroxycholesterol (Javitt, 2002). The most 
important pathway starts with 7α-hydroxylation of cholesterol by cholesterol 7α-
hydroxylase (CYP7A1), a hepatic cytochrome P-450 enzyme operating 
predominantly in the liver. This pathway is under strict metabolic control and the best 
known regulatory mechanism is the feedback control by bile acids reabsorbed from 
the intestine (Repa and Mangelsdorf, 2000). The bile acid sensor FXR, farnesoid X-
activated receptor, is a nuclear receptor highly expressed in the liver. Repression of 
CYP7A1 is mediated by hormone receptors denoted SHP and LRH-1 which both have 
FXRE (FXR response element) in their promotor sequence (Edwards et al., 2002). 
CYP7A1 is also regulated by LXRα in the mouse and also the rat, however, in 
humans, regulation via this route is an open question as no LXR-responsive elements 
are found in the promoter of the human CYP7A1 gene (Björkhem and Diczfalusy, 
2002; Edwards et al., 2002). 
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In addition to the 7α-hydroxylase pathway, an acidic pathway is also used in 
the liver to make bile acids. In contrast to CYP7A1, the enzyme catalyzing the first 
step in this route, CYP27A1, has a broad substrate specificity and is present in many 
tissues. Also, extrahepatic 27-oxygenated cholesterol is taken up by the liver and can 
be converted to bile acids via this route. It is estimated that 5-10% of the bile acids 
produced by this pathway are derived from extrahepatic 27-hydroxylation (Lund et 
al., 1996). 
As oxysterols can pass the blood-brain barrier, they are considered important 
in brain cholesterol metabolism. In the brain a high rate of cholesterol turnover 
occurs, possibly resulting from an extensive, highly active membrane trafficking in 
the nervous system (Lange et al., 1995; Lütjohann et al., 1996). The 24-hydroxylation 
of cholesterol to 24S-hydroxycholesterol is specific for the brain and the gene 
encoding this cytochrome P450 enzyme is CYP46. The expression of this gene in the 
brain is 100-fold greater than in other tissues (Lund et al., 1999). The importance of 
this pathway lies most probably in the transport of cholesterol out of the central 
nervous system as 24S-hydroxycholesterol has the ability to pass the blood-brain 
barrier in contrast to cholesterol itself. This hydroxysterol is then taken up by the liver 
and half of it is converted to bile acids while the other half is conjugated to sulfuric 
acid and/or glucuronic acid before excretion (Björkhem et al., 2001). 
The potency of 25-hydroxycholesterol (25-OHC) as an inhibitor of cholesterol 
synthesis has been known for a long time (Kandutsch et al., 1978), yet only recently 
the human cDNA of the enzyme responsible of its formation, CH25H, was described 
(Lund et al., 1998). This enzyme is expressed in many tissues and does not belong to 
heme iron containing proteins, as are the previous enzymes described in this chapter 
(Lund et al., 1998). The 25-hydroxylation product of cholesterol has no significant 
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role in bile acid synthesis and the amounts detected in the circulation are minor 
(Björkhem and Diczfalusy, 2002). 
Not only the oxysterols that are produced enzymatically, but also the ones 
formed by autooxidation are potent regulators of cellular cholesterol homeostasis. 
Many of these are highly cytotoxic, they are present in oxidized LDL, and could 
therefore contribute significantly towards the development of atherosclerosis (Panini 
and Sinensky, 2001; Vaya et al., 2001). 
There is mounting evidence for the proapoptotic activity of oxysterols and this 
includes inflammatory responses (Landis et al., 2002; Rosklint et al., 2002), foam cell 
formation (Hayden et al., 2002) and apoptosis (Panini and Sinensky, 2001). The two 
known apoptotic pathways are the extrinsic (death receptor pathway, Fas pathway) 
(Lee and Chau, 2001) and the intrinsic (mitochondrial pathway) (Lizard et al., 1998; 
Yang and Sinensky, 2000). In the Fas/Fas ligand-mediated pathway, death mediators 
like p53, FAS and FAS ligand are upregulated when smooth muscle cells (SMCs) or 
vascular epithelial cells are treated with oxidized LDL. Oxysterols like 7-OH or 25-
OH cholesterol were found to induce a similar response (Lee and Chau, 2001). The 
mitochondrial route involves the release of the cytochrome c from the mitochondria 
and the activation of caspase-9 (Walter et al., 1998). The work of Yang and Sinensky 
2000 and Lizard et al 1998 has shown that 25-OHC activates the cytochrome c 
release-mediated caspase cascade (Yang and Sinensky, 2000) and that 7-
ketocholesterol induces apoptosis using this same pathway (Lizard et al., 1998). 
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7. Oxysterol binding protein, OSBP 
 
In the early 1980s the launched hypothesis was that cholesterol synthesis is regulated 
via an oxysterol binding protein; a cytosolic component that bound to oxysterols 
(Taylor and Kandutsch, 1985). Today two protein families that are known to bind 
oxysterols have been described: The liver X receptors (LXRs) (Chawla et al., 2001) 
and the protein family described as cytoplasmic oxysterol receptors, termed oxysterol 
binding proteins (OSBPs) or OSBP related proteins, ORPs (see Results and 
discussion, chapters 1. –3. in this study; (Jaworski et al., 2001). The cDNA of the 
human OSBP protein was first described in 1990 by Levanon and others. In addition, 
there is a high degree of homology between OSBP proteins from human and other 
mammals (Levanon et al., 1990). 
The OSBP gene is located in the long arm of human chromosome 11 and the 
corresponding mouse gene is at the proximal end of mouse chromosome 19. OSBP is 
a cytosolic protein of 809 amino acids (Ridgway et al., 1992). Human and mouse 
OSBP cDNAs are 94% identical and the encoded proteins share 98% identity between 
their predicted amino acid sequences (Levanon et al., 1990). In SDS-PAGE the 
protein migrates as a doublet of 96 and 101 kDa. The slower migrating band 
represents a phosphorylated form. The phosphorylation is inhibited by the Golgi 
dissociating toxin brefeldin A because the rapid phosphorylation / dephosphorylation 
of OSBP requires interaction with Golgi membranes and an associated kinase 
(Ridgway et al., 1998a). OSBP is also rapidly dephosphorylated when plasma 
membrane SM is hydrolyzed by exogenous bacterial sphingomyelinase (Ridgway et 
al., 1998b). The structure of OSBP consists of two main parts: the N-terminal part of 
the protein which contains a pleckstrin homology (PH) domain (residues 87-185) and 
the C-terminal domain (residues 417-750) containing a sterol-binding (SB) domain 
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(Levine and Munro, 1998; Ridgway et al., 1992). The protein binds 25-OHC with 
high affinity, but it also interacts with many other oxysterols (Taylor et al., 1984). 
When OSBP is overexpressed in Chinese Hamster Ovary (CHO) cells it is 
partly soluble and partly bound to small perinuclear vesicles. Upon binding to its 
ligand the protein redistributes to the Golgi area. The PH domain is needed for this 
shift in localization as shown by using a truncated protein lacking the N-terminal 
region (Ridgway et al., 1992). Many of the proteins containing PH domains are 
involved in intracellular signaling and cytoskeletal organization, like protein kinases 
(Btk, β-ARK and Akt), phospholipase C (PLC) isoforms, insulin receptor substrates 
(IRS-1 and –2), the phosphoinositide 3-kinase (PI3-kinase) p110γ subunit, the 
guanine nucleotide release factor SOS, the GTPase-activating protein rasGAP and the 
dynamin GTPase. Four proteins, pleckstrin, CDC25, PLC-γ and Tiam1 contain two 
copies of a PH domain (Bottomley et al., 1998). Sequence similarity between 
different PH domains is low (10-20%). This could implicate that their function in cells 
is diverse in accordance with the fact that they bind a variety of different 
phosphoinositides as well as proteins. Lefkowitz and co-workers showed that the C-
terminal portion of the PH domain and the sequences flanking the PH domain in 
several proteins bind to the βγ-subunit of G proteins (Touhara et al., 1994). The 
results of Kawakami and co-workers suggest that the PH domains of several proteins 
bind to filamentous but not to monomeric actin (Yao et al., 1999). Models for 
prediction of the ligand binding characteristics of PH domains are under study and 
some classification of proteins containing PH domains has been done. In one 
classification Maffucci and Falasca (2001) divide the domains into three groups. In 
the first group there are PH domains that bind with very high affinity to specific 
phosphoinositides like PI(4,5)P2 (PLC-δ1), PI(3,4,5)P3 (Btk and Grp1), and these 
proteins are targeted to the PM. In the second group the PH domains bind with lower 
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affinity/or specificity to phosphoinositides and are unlikely to be sufficient to drive 
the translocation of proteins to the PM (Gap1, Dbl, IRS-1). The third group includes 
PH domains that bind non-specifically to phosphoinositides such as in pleckstrin, 
DAGK-δ and dynamin (Maffucci and Falasca, 2001). 
Levine and Munro have studied the targeting of the PH domain of OSBP 
(PHOSBP) and other related PH domains in yeast using GFP-PH domain fusion 
proteins. There are several proteins that have a PH domain highly related to that of 
OSBP. These include Goodpasture antigen binding protein (GPBP) in human and 
PtdIns 4-phosphate adaptor protein-1 (FAPP1) in several mammals. The function of 
these proteins is not known, but the similarity in PH sequence to that of OSBP raises 
the possibility of similarity in subcellular targeting (Levine and Munro, 2002). 
Previously, PHOSBP was shown  in vitro to bind both PI(4)P and PI(4,5)P2 and the 
cleavage of the headgroup of the phosphoinositides by phospholipase δ1 blocked 
PHOSBP targeting to Golgi membranes (Levine and Munro, 1998). It may be that the 
targeting determinant for Golgi membranes is PI(4)P, although it is unlikely that the 
localization of PI(4)P is strictly restricted only to Golgi membranes. In addition, 
analysis of a mutant version of PHOSBP, which does not bind to phosphoinositides, 
shows some Golgi targeting that is dependent on Arf1p but not on PtdIns 4-kinase1 
(Pik1) activity. So it seems that Golgi targeting of PHOSBP involves both Pik1-
dependent and –independent components (Levine and Munro, 2002).  
Neale Ridgway and co-workers have studied the connection of the OSBP 
protein to cholesterol and sphingomyelin (SM) metabolism. Using CHO-K1 cells 
stably overexpressing OSBP, they show that cholesterol synthesis is upregulated by 
the protein. When mock cells and cells overexpressing OSBP are treated with 25-
OHC the synthesis of cholesterol decreases in both cells (Lagace et al., 1997). They 
have also shown that OSBP stimulates the upregulatory effects of 25-OHC on SM 
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synthesis (Lagace et al., 1999). It appears that the transition of OSBP from the cytosol 
to the Golgi upon binding to 25-OHC stimulates the conversion of ceramide to SM.  
Upregulation of cholesterol esterification after 25-OHC treatment is of the same 
magnitude in both the control cell line and in the OSBP overxpressing cells, which 
implicates that OSBP does not activate ACAT (Storey et al., 1998). The protein seems 
to be involved in both cholesterol and SM metabolism, but its precise function is still 
unrevealed (Lagace et al., 1997; Lagace et al., 1999). Further, there is evidence that 
OSBP affects the trafficking of both proteins and ceramide from the ER to the Golgi 
(Wyles et al., 2002). These latest results together with the proposed function of an 
OSBP related protein from yeast, Kes1, in Golgi vesicle trafficking (Fang et al., 1996; 
Li et al., 2002), suggest that OSBP and related proteins may have an important role in 
intracellular transport of lipids and proteins.  
 
8. OSBP-related proteins 
 
Since the discovery of the human OSBP protein there has been a tremendous step 
forward in finding new homologues in different organisms. In the human family there 
are now 12 proteins (OSBP and ORP1-11; in this study) and the corresponding genes 
are also found in the mouse (Anniss et al., 2002),. In yeast there are 7 proteins 
(Osh1p-7p) see Results section and (Beh et al., 2001; Jiang et al., 1994). In addition to 
these, other eukaryotes like Drosophila melanogaster (OSBP-Dm) (Alphey et al., 
1998) and Caenorhabditis elegans (Sugawara et al., 2001) are known to have OSBP 
homologues. The yeast OSBP homologues can be divided into two groups: the short 
homologues containing only the oxysterol binding domain (Osh4p-7p) and the long 
homologues containing also an N-terminal stretch with the PH domain (Osh1p-3p). In 
addition, Osh1p and Osh2p contain ankyrin repeats in the N-terminal sequence. 
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Ankyrin repeats mediate protein-protein interactions and are found in many 
cytoskeletal proteins and in some transcription factors (Sedgwick and Smerdon, 
1999). There is no cholesterol in yeast, but instead there is ergosterol, a major 
component of yeast cell membranes (Zinser et al., 1991). Beh and co-workers have 
studied the functions of all seven OSBP homologues in yeast. They created 
disruptions of each gene either alone or in different combinations and found that none 
of the single disruptions were lethal. Only when all of the seven genes were disrupted, 
yeast cells no longer survived (Beh et al., 2001). The intracellular localization of 
Osh1p, Osh2p and Osh3p has been studied in yeast using N-terminal GFP fusion 
constructs (Levine and Munro, 2001). Under normal growth conditions Osh1p 
localizes both to the Golgi and the nucleus-vacuole (NV) junction. The domain 
responsible for the NV junction localization is the ankyrin domain of the protein. 
Even when the PH domain of Osh1p is replaced with that of spectrin (this PH domain 
does not show any specific localization alone) the protein localizes to the NV junction 
but no longer to the Golgi region. Thus, the PH domain contains Golgi targeting 
information. Although Osh2p has three ankyrin repeats in the N-terminus, it does not 
target to the NV junction, nor does the fusion protein containing Osh2p ankyrin 
region and Osh1p PH and OSBP domains. Osh2p localizes to the PM, especially to 
the budding area of G1 phase cells and to the bud-neck in S-phase cells. Osh3p, the 
Osh protein that contains an N-terminal PH domain but no ankyrin repeats, seems to 
have more diffuse localization throughout the cytoplasm (Levine and Munro, 2002). 
Recent results from two-hybrid analysis of Osh3p interaction partners show that this 
protein interacts with the DEAD-box RNA helicase called Rok1p that is involved in 
nuclear fusion during yeast mating. It is also possible that the protein may function 
either parallel to or downstream of the STE12 (STE = “sterility genes”) transcription 
factor and be involved in the regulation of filamentous growth of yeast (Park et al., 
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2002). Osh4p, more commonly known as Kes1p is implicated in Golgi vesicle 
trafficking. It is known that in yeast the phospholipid transfer protein Sec14p is 
required for biogenesis of Golgi-derived transport vesicles (Bankaitis et al., 1990). 
The Sec14p defect can be bypassed by Kes1p defect. The dysfunction of this protein 
leads to reduced metabolic flux through the CDP-choline pathway of PC synthesis 
and in that way diminishes the toxic effect of the deletion of Sec14p (Fang et al., 
1996). Recent data indicate that Kes1p could be a phosphoinositide binding protein 
and that specific phosphoinositides, especially PI(4)P are required for Golgi 
localization of Kes1p. The Golgi localization is necessary for the function of the 
protein. Kes1p function is also connected to that of ARF in yeast (Li et al., 2002). 
The detailed description of the family of 12 human OSBP homologues is 
presented later in the Results and discussion section. In the following paragraph I will 
give an overview of the present status of the OSBP homologues. 
According to Xu and collagues (Xu et al., 2001) the human homologues of 
OSBP, ORP1 (short variant) and ORP2, bind phospholipids in vitro. ORP1 and ORP2 
seem to bind PA in a dose dependent manner. The proteins were also reported to bind 
PI(3)P and cardiolipin with apparently lower affinity. ORP2 localizes mainly to the 
Golgi (Xu et al., 2001) and intracellular localization of the GFP-ORP1 is cytosolic. 
Recent data by Marie Johansson and co-workers, however, indicates that the 
intracellular localization of the long ORP1 variant is not in the Golgi, but rather in 
endosomal membranes (Johansson et al., 2002). ORP3 is differentially expressed 
during differentiation of specific hematopoetic cell populations and may have a role in 
mediating oxysterol effects on hematopoiesis (Gregorio-King et al., 2001). ORP4 
(OSBP2) is shown to be highly expressed in the retina and it binds both 7-
ketocholesterol and 25-hydroxycholesterol (Moreira et al., 2001; Wang et al., 2002). 
Results from the group of N. Ridgway show that a longer form of the ORP4 protein 
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containing the PH domain binds efficiently 25-hydroxycholesterol and to a lesser 
extent 7-ketocholesterol. A shorter form without the PH-domain shows poor binding 
of both oxysterols. The shorter form of the protein, however, binds to vimentin 
intermediate filaments and overexpression of the protein decreases the esterification 
of LDL-derived cholesterol (Wang et al., 2002). Further, ORP4 is suggested to be a 
marker protein for the detection of metastatic tumor cells derived from solid tumors in 
the peripheral blood (Fournier et al., 1999). 
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AIMS OF THE STUDY 
 
 
1. To identify new human proteins related to oxysterol binding protein, OSBP, 
and to analyze their expression patterns.  
2. To determine the tissue expression pattern and the cellular localization of one 
family member named OSBP Related Protein 2 (ORP2). 
3. To characterize the functional role of this protein in cellular lipid 
metabolism.  
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METHODS 
 
All the methods used in the original articles are summarized in the following table: 
 
Method        Publication 
Generation of cDNA fragments corresponding to EST contigs  I, II 
Cloning of ORP cDNAs       II 
Cell culture         I - IV 
Transfections and selection of stably transfected CHO cells   III 
RNA extraction and Northern blot hybridization    I 
Measurement of ORP mRNA levels by semiquantitative RT-PCR  II 
Determination of the ORP2 mRNA tissue expression pattern  I, II 
In situ hybridization        III 
Antibodies         III 
Western blotting        III 
Flotation of cellular membranes in sucrose gradients   III 
Immunofluorescence microscopy      III 
Analysis of cholesterol synthesis and transport    IV 
Analysis of phospholipid synthesis      IV 
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RESULTS AND DISCUSSION 
 
1. The search for human cDNAs encoding OSBP-related proteins, ORPs 
(I,II) 
 
To gain insight into the cellular effects of oxysterols we began searching for potential 
cellular receptors specific for oxysterols. For the first search (I), we used the 
tBLASTn program to scan the National Center for Biotechnology Information (NCBI) 
dbEST database for human cDNA sequences that were homologous to the sterol-
binding region of OSBP (amino acid residues 297-807). The reason for using the 
sterol-binding domain only was that use of the full-length sequence containing the PH 
domain would most probably have resulted in finding numerous PH-domain proteins 
not belonging to the OSBP-family. In order to exclude extremely short and/or poor 
quality sequences we set the P value cutoff level to 0.0001. The search yielded 40 
human ESTs, seven of which represented OSBP itself. The remaining ones were 
grouped to contigs using the University of Wisconsin Genetics Computer Group 
(GCG) software. As a result, 8 new sequences were found, that had clear homology to 
OSBP. They were named OSBP-Related-Proteins, ORPs, number 1-8. Contigs 7 and 
8 were so short that they were omitted from further analysis. The next step was to 
combine cDNA cloning techniques and computational analysis for determining the 
full-length ORP cDNA sequences (II). During the cloning process, it became evident 
that the previously described ORP 7 and 8 ESTs were derived from ORP4 and OSBP. 
In addition to ORP1-6, two novel ORP gene products closely related to ORP3 or 5 
were identified. These genes were named ORP7 and 8, respectively. During the 
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database analysis of the full-length cDNAs of ORP1-8, we discovered three additional 
cDNAs and these were designated ORP9-11 (II). 
 
2. Functional domains and structural relationships of ORPs (II) 
 
The ORP amino acid sequences were deduced from cDNA sequence information. 
There are two major structural features of OSBP (the founder member of the protein 
family). Near the N-terminal end is the PH domain and at the C-terminal end is the 
sterol-binding (SB) domain (Lagace et al., 1997). By computational analysis, nearly 
all of the novel ORP family members have been found to contain the same structural 
features. The most conserved region, the SB domain, consists of approximately 400 
amino acids. Interestingly, within the SB domain there is an eight amino acid motif 
(EQVSHHPP) that is fully conserved across all of the human family members. A PH 
domain is also found in all members except for ORP2 (after publication of article II, a 
PH domain in ORP9 was also discovered). Additional features in the structure of 
some of the proteins were also found. Three ankyrin-like repeats were identified at the 
N-terminal end of ORP1. Ankyrin repeats are also present at the N-terminal end of the 
yeast OSBP homologues, Osh1 and Osh2. In addition, ORP5 and ORP8 contain 
potential membrane spanning segments in the C-terminal ends. According to amino 
acid sequence and intron-exon structure, the ORP genes can be devided to six 
subfamilies. Compared to the yeast family of OSBP homologues, ORP2 resembles the 
four short category of ORPs called Osh4/Kes1p, Osh5/Hes1p, Osh6/Yhg1p and 
Osh7/Yky3p. Functional data available from Kes1p indicates that this protein is 
involved in Sec14p-dependent Golgi vesicle trafficking in yeast (Li et al., 2002).  
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3. Tissue expression patterns of ORPs (I,II) 
 
For the first article it was crucial to verify that the novel sequences were expressed 
and that they represented distinct genes. In the third article a detailed analysis of 
ORP2 tissue expression, both at the mRNA and the protein level, was also included. 
 
3.1 Analysis of ORP mRNA expression by Norhthern Blotting (I) 
The cDNA probes for each fragment were designed as similar in length as possible to 
obtain comparable signals for the different mRNAs, and were labeled to a specific 
activity of 1.5-3 x 108 cpm/µg. Commercially available human multiple tissue 
Northern blots were hybridized according to the manufacturer’s instructions. OSBP, 
the expression of which is reported to be ubiquitous (Dawson et al., 1989; Ridgway et 
al., 1992) was included in this analysis for comparison. We found that the OSBP 
mRNA was indeed ubiquitously expressed and that the signal was strongest in the 
liver and kidney. ORP1, also expressed ubiquitously, was most abundant in the brain, 
heart, skeletal muscle and kidney. Another new sequence that gave rise to a relatively 
strong signal was ORP2. With ORP2, we noted a number of differently sized mRNAs 
suggesting a high degree of differential splicing. The main forms of ORP2 mRNA 
were 4.4 and 2.8 kb in length, were highly expressed in the brain, heart and kidney 
and were also present in the liver and placenta. In the heart and in skeletal muscle we 
detected two additional forms at 6.6 and 1.2 kb in length. In the brain a minor 6.0 kb 
mRNA was also seen. The hybridization signals from the remaining ORPs were 
weaker yet clearly tissue-specific. Various sizes of ORP3 mRNAs (7.0, 4.5 and 3.5 
kb) were detected at very low levels, the most prominent signals being in spleen and 
white blood cells. The ORP4 mRNAs were most abundant in the brain (4.8 and 3.8 
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kb) and heart (3.5 kb mRNA species) tissues. The size of ORP5 mRNA was 4.0 kb 
and this was equally expressed at low levels in all of the tissues studied. However, the 
signal was slightly higher in thymus and peripheral blood leukocytes. The weakest 
signals were obtained with the ORP6 probe. These signals were clearest in brain (7.2 
kb) and skeletal muscle (4.0 and 3.5 kb). 
The expression of ORP1 mRNA in different regions of the brain was studied 
further by Northern blotting; The 3.6 kb mRNA was most abundant in the cortical 
area as compared to the cerebellum and spinal cord. The next step was to study the 
possible effects of sterol status in neuronal cells on ORP1 mRNA. The human 
neuroblastoma cell line, SHEP, was grown either in the presence of 10% fetal bovine 
serum or in 5% lipoprotein deficient serum. After 2 days delipidation the cells were 
either loaded with LDL for 24 hours or treated with 25-OHC for 4 hours. LDL 
loading upregulated ORP1 mRNA approximately 2-fold, whereas treatment with 25-
OHC gave a minor, 1.5-fold upregulation. The concentration of 25-OHC that was 
used has been reported in CHO cells to cause a translocation of OSBP from the 
cytosol to the Golgi (Ridgway et al., 1992). We carried out a similar experiment using 
the human hepatoma cell line HuH7, however, no significant alterations in ORP1 
mRNA level were found. These results implied a specific role for ORP1 in brain 
sterol balance. In the brain the major oxysterol produced is 24S-OHC (Bjorkhem et 
al., 1998). One could presume that treatment with 24S-OHC would induce a more 
significant change in ORP1 expression. Unfortunately, at the time of the experiments, 
24S-OHC was not available, and so it was not possible to test the connection between 
24S-OHC and ORP1 expression. 
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3.2  Detailed analysis of ORP2 mRNA expression in human tissues (III)  
For a more detailed analysis of the tissue distribution of ORP2 mRNA, a human MTE 
(Multiple Tissue Expression) filter array was hybridized using the radioactively 
labeled full-length ORP2 cDNA as a probe. The ORP2 message was detected in all 
tissues/cells studied and the signal was quantitated using the phosphorimager 
technique. The quantitation revealed that the highest levels of ORP2 mRNA were in 
specific parts of the central nervous system (cerebellum, pituitary gland, pons, and 
putamen) as well as in leukocytes, placenta, and pancreas. The strongest signal was 
from the cerebellum and this was 10-fold higher than the weakest signal detected in 
the ovary. These results verified the previous finding that ORP2 has a ubiquitous 
expression pattern in human tissues and that the highest expression is found in the 
brain. 
 
3.3  In situ hybridization analysis of ORP2 mRNA in mouse embryonic tissues 
(III) 
To determine if the expression of ORP2 mRNA in mammalian tissues is concentrated 
in specific cell types, in situ hybridization of sections from 12-day old mouse embryos 
was performed. This analysis showed that the ORP2 mRNA was ubiquitous and 
evenly distributed, however, the expression in certain tissues, such as parts of the 
spinal cord, dorsal root ganglia and the inferior ganglion of the vagus nerve, was more 
prominent. This ubiquitous distribution of the message suggests that ORP2 may have 
a housekeeping function in mammalian cells and that in the brain and in other parts of 
the nervous system, whose cholesterol content is the highest of all tissues (Björkhem 
et al., 1998; Dietschy and Turley, 2001), the expression of the gene is elevated. 
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3.4 ORP2 protein expression in mouse tissues (III) 
To analyse ORP2 distribution in different tissues at the protein level, various mouse 
tissues were homogenized and equal amounts of total protein (15 µg) were analyzed 
by Western blotting. A rabbit antibody was generated against a GST-ORP2 fusion 
protein expressed in E. coli. The antibodies were affinity purified using the GST-
ORP2 fusion protein, and in Western blots of CHO cell lysates they recognized a 
major endogenous protein band of 56 kDa as well as additional 60 kDa and 51 kDa 
bands. The 56 kDa band corresponds to the protein encoded by the cloned cDNA. In 
the majority of mouse tissues this antibody revealed two major bands with apparent 
molecular masses of 56 and 51 kDa. An expression pattern similar to that seen in the 
Northern blots or by in situ hybridization was also seen in the Western analysis of 
mouse tissues. ORP2 is ubiquitously expressed and the brain tissue contains the 
highest amount of this protein. Interestingly, both forms of the protein have slightly 
different distributions among the mouse tissues. The higher molecular mass (56 kDa) 
band is absent in liver and kidney whereas skeletal muscle lacks the 51 kDa band. 
Variation between the relative abundance of these bands is also apparent across 
different tissues. It is possible that these two immunoreactive forms of the protein 
represent variants translated from differently spliced mRNAs or that the 51 kDa form 
is proteolytically cleaved from the larger form. Taken together all of the expression 
data obtained thus far supports the suggestion that ORP2 may have a housekeeping 
function in cells, and in certain specialized cells, like in the nervous system, higher 
expression of this protein may be needed.  
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4. Intracellular distribution of the ORP2 protein (III) 
 
The intracellular protein distribution of ORP2 was studied by cell fractionation and by 
indirect immunofluorescence microscopy. At the time, published data on the 
subcellular localization of any other ORPs was unavailable. Fortunately, our antibody 
recognized the endogenous ORP2 protein in CHO cells, and thus enabled us to study 
the localization of ORP2 without overexpressing the protein. The post-nuclear 
supernatant of CHO cells was fractionated by ultracentrifugation in sucrose step 
gradients and was followed by Western blotting. Syntaxin 2, an integral membrane 
protein, was used as a control for the total membrane fraction. The 56 and 51 kDa 
forms of the protein distributed between membrane (20%) and soluble (80%) 
fractions. Interestingly, the 60 kDa band was entirely membrane associated. The 
affinity-purified antibody was used for immunofluorescense microscopy and both the 
endogenous and stably overexpressed ORP2 protein were found to localize to the 
cytosol and to the perinuclear region in CHO cells. The co-localization with different 
cellular markers was studied and the bright perinuclear aspect of the staining 
coincided partially with a Golgi marker, FITC-lentil lectin. It is obvious that another 
mechanism than that of the PH domain is responsible for ORP2 protein association 
with membranes. A detailed analysis of the localization of the yeast ORP proteins, 
Osh1p, 2p and 3p, was recently published (Levine and Munro, 2001). All of the 
proteins contain a PH domain but only Osh1 is localized to the Golgi and in addition, 
it localizes to the nuclear-vacuolar junction via its ankyrin repeat sequence. There are 
also indications that sequences flanking the PH domain are important for the targeting 
specificity of Osh proteins and it is possible that this could be a more general feature 
in the OSBP family (Levine and Munro, 2002). In Osh4p (Kes1p), a short ORP 
protein, the Golgi localization and binding of phosphoinositides are needed for its 
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function in vesicular trafficking. It is postulated that the ligand binding domain of 
Osh4p has a PH domain like structure (Li et al., 2002). Therefore, the lipid binding 
properties of possible PH domain-like structures within the ORP ligand-binding 
domain, may play a role in targeting these proteins to specific locations. At the time 
of these studies Xu and others reported that a variant of ORP2 lacking amino acid 
residues 13-24 does not bind oxysterols (Xu et al., 2001). Instead, ORP2 was reported 
to interact with phosphatidic acid (PA) and weakly with inositol-3-phosphate. 
 
5. The effect of ORP2 overexpression on marker protein trafficking 
through the secretory pathway (III) 
 
By transiently overexpressing ORP2 in CHO cells, we were able to study the effect 
that this may have on the trafficking of GFP-tagged vesicular stomatitis virus G 
(VSVG) protein through the secretory pathway. The VSVG that was used carries the 
temperature sensitive ts045 mutation that causes its arrest to the ER at 40oC. CHO 
cells were double transfected either with a control plasmid (pcDNA3.1/CAT) or with 
pcDNA3.1/ORP2 together with the VSVG-GFP expression vector. Cells were then 
grown at 40oC for 20 hours during which time the VSVG-GFP accumulated in the 
ER. The temperature block was then released in by lowering the temperature to 32oC 
and incubating the cells for increasing time periods. In cells transfected with the 
control plasmid, VSVG-GFP was in the Golgi after 1 h, and after 4 h the marker had 
reached the PM. In cells overexpressing ORP2, transport to the Golgi was unaffected. 
However, transport from the Golgi to PM was inhibited as evidenced by the fact that 
even after 4 hours at 32oC, Golgi structures displayed a strong fluorescence. This was 
observed specially in the cells with extensive overexpression of ORP2.  
 48
The yeast OSBP homologue, Kes1p (Osh4p), is implicated in Golgi vesicle 
transport (Fang et al., 1996; Li et al., 2002). In addition to the finding that inactivation 
of Kes1 bypasses the Sec14p defect (Fang et al., 1996), new data revealed that Kes1p 
could regulate the ARF cycle in Golgi vesicle transport (Li et al., 2002). Xu and co-
workers have shown that when human ORP2 is overexpressed in yeast, trafficking of 
carboxypeptidase Y to the vacuole is disturbed (Xu et al., 2001). The above findings, 
together with the functional data on OSBP (Wyles et al., 2002), support the notion 
that ORP2 may have a role in vesicular trafficking. 
 
6. Lipid metabolism in stably transfected CHO cells overexpressing 
ORP2 (III,IV) 
 
To determine whether ORP2 is involved in the control of cellular lipid metabolism, 
we created stably transfected cell lines overexpressing the protein. All of the results 
we obtained from the ORP2 expressing cells (ORP2/CHO) were compared to a mock 
transfected cell line containing the empty vector. 
 
6.1 Cholesterol efflux (III) 
We first studied the effects of ORP2 expression on the cholesterol efflux process by 
labeling the cells with [14C]cholesterol for 36 hours. The cells were then washed and 
efflux was performed to various acceptors. Three different acceptors were used. Small 
unilamellar PC vesicles (0.3mg PC/ ml) were used for studying non-specific 
diffusion, human apoA-I (20µg/ml) for possible effects on the more specific ABCA1 
mediated pathway and human serum (20 %) was also used as it is a physiological 
acceptor that represents a combination of both efflux routes. ORP2 enhanced the 
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efflux of [14C]cholesterol to a similar extent to all of the acceptors. The change in 
efflux may be caused by changes in the trafficking machinery involved in the process. 
Another possibility could be a change in the lipid composition in the membranes, 
especially the PM. Alterations in the synthesis, uptake or esterification of cholesterol 
could also affect the cholesterol efflux. More rapid or slow recruitment of cholesterol 
from the stores could also have an effect on the efflux. According to the results 
obtained it seems that the ORP2 effect was not specific for any single efflux route 
studied (Fielding and Fielding, 2001b). 
 
6.2 Cholesterol biosynthesis (IV) 
To see if the stable expression of ORP2 affects cholesterol synthesis the cells were 
grown in either complete medium or in delipidated medium. The cells were then 
pulse-labeled with [3H]acetate for 15 minutes, followed by a 2 hour chase in the 
presence of mevalonate and lovastatin to inhibit further cholesterol synthesis, and the 
amount of the synthesized [3H]cholesterol was measured. In these experiments 
cholesterol synthesis was upregulated approximately 3 fold when cultured in 
lipoprotein deficient medium as compared to cells grown in complete medium and 
this was observed in both control and ORP2 cell lines. In both growth conditions, the 
ORP2 cells displayed 40 to 60 % down regulation of the cholesterol biosynthesis as 
compared to the control. Thus overexpression of the ORP2 protein decreased 
cholesterol synthesis in CHO cells. The effect was opposite to that obtained with 
OSBP; In CHO cells overexpressing OSBP, cholesterol synthesis was enhanced. The 
overexpression of OSBP together with the addition of 25-OHC decreased cholesterol 
synthesis in the same way as the addition of oxysterol alone indicating that other 
mechanisms are mediating this oxysterol induced effect (Lagace et al., 1997). 
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6.3 Transport of newly synthesized cholesterol to the cell surface (IV) 
The finding that ORP2 affected the transport of the marker protein via the secretory 
route, as described above, led us to examine the transport of newly synthesized 
cholesterol from the ER to the PM. For this we first cultured the cells in lipoprotein 
deficient medium to induce cholesterol synthesis and then labeled the cells in the 
same way as for the biosynthesis study. To detect the cholesterol that had reached the 
PM, methyl β-cyclodextrin was added to the chase medium for the final 5 minutes 
and the amount of [3H]cholesterol was measured from both the media and the cells 
(method described by (Heino et al., 2000)). Approximately 20% of the [3H]cholesterol 
became accessible to cyclodextrin in the control cells while in the ORP2/CHO cells 
about 30% of the [3H]cholesterol synthesized had reached the PM and was accessible 
to cyclodextrin. Therefore, the enhancement observed in ORP2/CHO cells was 
approximately 50%. The possible mechanism behind this enhanced accessibility of 
[3H]-cholesterol to cyclodextrin may be that ORP2 affected the PM lipid composition 
so that cholesterol would more easily transfer to cyclodextrin or that the transport 
process of the newly synthesized cholesterol between the ER and the PM was 
enhanced. The first possibility was analyzed by mass spectrometry as described later 
(Results and discussion paragraph 7). The second possibility, i.e. that the transport of 
cholesterol was enhanced by ORP2, could in theory be due to an inhibition of the 
transport via the secretory pathway that could in turn induce an alternative, Golgi 
independent cholesterol transport route (Heino et al., 2000). ORP2 could also be 
involved in the formation or in the function of some yet unidentified type of vesicles 
transporting cholesterol to the PM. 
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6.4 Cholesterol esterification (III-IV) 
In cellular cholesterol metabolism it is important that the balance between free and 
esterified cholesterol is regulated precisely. According to our results most of the 
cholesterol in CHO cells is in the free form and only 2-10 % is esterified. This 
depends on the growth conditions and the physiological status of the cells. 
 
6.4.1 Esterification of [14C]cholesterol (III-IV) 
The stably transfected cells were labeled with [14C]cholesterol for 36 hours and to 
analyze the amount of esterified [14C]cholesterol, the cells were collected and the 
extracted lipids were separated by thin layer chromatography. Both the free and 
esterified cholesterol were scraped off the plate and the radioactivity was measured by 
liquid scintillation counting. The proportion of total [14C]cholesterol found in the 
esterified form was drastically reduced in the ORP2/CHO cells (40-50 %) as 
compared to mock transfected cells. The change in the esterification of the 
[14C]cholesterol could be due to several alternative mechanisms. The transport of 
cholesterol to the ER where the esterification occurs could be impaired, the transport 
or the synthesis of the fatty acyl-CoA could be affected or the hydrolysis of 
cholesterol esters or the ACAT activity itself could be affected. 
 
6.4.2 ACAT activity (III) 
To analyze whether the lowering of cholesterol esterification could be due to a 
decrease in ACAT activity in ORP2/CHO cells, [14C]oleyl-CoA incorporation into 
cholesterol esters in semi-purified  cellular membranes was determined. The assay 
was performed in the presence of exogenously added cholesterol (20µg / ml final 
concentration) to compensate for possible differences in the amount of the free 
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cholesterol pool. The ACAT activity of the ORP2/CHO cells was found to be reduced 
by approximately 45%. No SRE element has been found in the promotor regions of 
the ACAT1 and ACAT2 genes and it seems that both genes are regulated at the post-
transcriptional level (Buhman et al., 2000; Chang et al., 2001). Regulation may be 
allosteric since no changes in ACAT1 mRNA or protein expression levels could be 
seen in cholesterol loaded macrophages, even when cholesterol esterification was 
increased (Wang et al., 1996). What then are the regulatory mechanisms influenced 
by ORP2 that are causing the decrease in esterification? It is possible that ORP2 is 
affecting the transport mechanisms of lipids and cholesterol in the cells and that 
ORP2 in that way modulates the substrate availability or localization of the ACAT 
enzyme. It is possible that in the ORP2 expressing cells the membrane environment 
where ACAT resides is changed. The in vitro assay of ACAT activity however, 
represents a more direct measure of the ORP2 effect and indicates that the enzyme 
activity is truly reduced. If the decreased ACAT activity were a primary effect of the 
protein then the previously described enhancement in cholesterol efflux would be 
secondary. To test this we conducted an experiment where we labeled the cells with 
[14C]cholesterol, used an ACAT inhibitor to inhibit esterification and then performed 
the efflux to 20 % serum. The esterification was lowered 99 % in both cell lines. 
Efflux in ORP2/CHO cells was still enhanced compared to mock cells, but now the 
difference was approximately one half of that seen without the ACAT inhibitor. This 
result indicates that the enhancement in cholesterol efflux is partly due to the lowering 
of esterification, but it does not fully explain the ORP2 effect on cholesterol efflux. 
Also other mechanisms are likely to be involved that probably reflect changes in the 
lipid distribution in cellular membranes or in intracellular lipid transport. 
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6.5 Phospholipid biosynthesis (IV) 
To analyze whether ORP2 overexpression results in alterations in phospholipid 
metabolism, we studied the synthesis of selected phospholipids in the stable cell lines. 
 
6.5.1 Phosphatidylcholine (PC) biosynthesis analyzed by [methyl-3H]-choline 
labeling (IV) 
To determine whether the expression of ORP2 also induces changes in PC synthesis 
we labeled the cells for two hours with [methyl-3H]choline chloride. Before labeling, 
the cells were grown in lipoprotein deficient medium for 36 hours. Lipids were 
extracted and analyzed by HPTLC. There was a significant 30-40 % increase in PC 
synthesis in ORP2/CHO cells as compared to mock cells. This could be associated 
with the enhanced efflux of newly synthesized cholesterol to cyclodextrin. Being a 
major phospholipid in eucaryotic membranes and therefore in intracellular vesicles, 
an ongoing synthesis of PC is required. Alterations in PC synthesis / turnover may be 
reflected in membrane trafficking (Howe and McMaster, 2001). This would be in 
agreement with our results that ORP2 affects trafficking in the secretory pathway. 
Vesicular transport and PC synthesis must be coordinated and one important factor is 
the Sec14p, a phosphatidylcholine and/or phosphatidylinositol transfer protein. Xu 
and co-workers have shown that ORP2 binds the PC metabolite, PA (Xu et al., 2001). 
The importance of PC, PA, DAG and phosphoinositides in vesicular transport has led 
to intense study and undoubtedly PC is one of the important connectors between 
membrane transport and the metabolism of lipids. 
 
6.4.2 Phospholipid biosynthesis analyzed by [3H]-serine labeling 
According to previous studies, changes in the cellular or PM sphingomyelin content reflect changes in 
cholesterol synthesis and efflux (Fukasawa et al., 2000; Kronqvist et al., 1999; Ohvo et al., 1997). 
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Based on these findings, we analyzed SM synthesis in the ORP2/CHO cells by [3H]-serine labeling. 
Lipids were extracted and different phospholipids were separated by HPTLC. No significant difference 
in SM synthesis was observed in ORP2 expressing cells as compared to the mock cells. 
 
7. Phospholipid content of the stably transfected cell line (IV) 
 
One possible explanation for the increased cholesterol efflux in ORP2/CHO cells 
could be that the phospholipid content or the saturation degree and/or chain length of 
the FAs in phospholipids was altered in ORP2 overexpressing cells. This could lead to 
more rapid cholesterol desorption from the membranes. To analyze whether the 
phospholipid content of the cells was altered cellular lipid extracts were subjected to 
mass spectrometric analysis. Both ORP2/CHO cells and mock-transfected cells were 
cultured in either complete medium or in lipoprotein deficient medium for 36 hours 
before lipid analysis. Differences in the relative proportions of the major phospholipid 
classes were not observed under either of the growth conditions. Hence, the enhanced 
PC synthesis observed in the ORP/CHO cells was not reflected by the total cellular 
amount of PC in the cells, which was the same as in the mock-transfected cells.  
Analysis of the FA composition in different PLs revealed that when cells were 
grown in delipidated medium the PE, PS and PI polyunsaturated species, which are 
mostly obtained from the serum lipoproteins, were reduced in ORP2/CHO cells and 
were replaced with mono- and diansaturated species. The loss of the polyunsaturated 
FAs was compensated for mainly by synthesis of oleic acid (18:1) as evidenced by an 
increase in the 34:1, 36:1 and 36:2 species. The reason for this phenomenon is still not 
clear. The polyunsaturated FA species could be more rapidly degraded by β-oxidation 
in ORP2/CHO cells or they could be lost to the external medium. The loss would then 
be replaced by using newly synthesized FAs for PL synthesis. The decreased ACAT 
activity is one possible explanation for the change in FA species. The enhanced loss 
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of the polyunsaturated species might be connected with the observed defect in ACAT 
activity. The two ACAT isoforms show differential substrate fatty acyl-CoA 
preferences as human ACAT1 strongly prefers oleic acid while ACAT2 also utilizes 
polyunsaturated fatty acids efficiently (Cases et al., 1998; Seo et al., 2001). Therefore, 
lowering of ACAT2 activity could theoretically lead to reduced storage of 
polyunsaturated fatty acids in the form of cholesterol esters and thus increase their 
turnover rate. However, the expression of the two ACAT isoforms in CHO cells and 
their substrate specificity have not been addressed in detail. 
 
8. Western analysis of SREBP-1 (IV) 
 
We were interested to see if the maturation of SREBPs in ORP2/CHO cells would be 
affected. For the maturation of SREBP to occur, the precursor must be transported 
from the ER to the Golgi where proteolytic cleavage takes place. We analyzed both 
control and ORP2/CHO cells by Western blotting using a mouse monoclonal antibody 
against SREBP-1a (Wang et al., 1993). We found that the maturation of SREBP was 
partially inhibited in ORP2/CHO cells. This could provide a plausible explanation for 
the reduction in the cholesterol de novo synthesis as seen in ORP2/CHO cells.  
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CONCLUSION 
 
We have identified a new human protein family that is related to the oxysterol binding 
protein (OSBP). We named the proteins OSBP related proteins, ORPs. The ORP 
genes are widely distributed in different chromosomes, which implies that they are of 
considerably old descent. According to their deduced amino acid sequences and 
intron-exon structures, the ORP genes can be divided into six subfamilies. The mRNA 
expression data suggests that the ORP genes have a ubiquitous distribution but are 
subject to tissue-specific transcriptional regulation. The sterol-binding domain is the 
most conserved part of the proteins and located within this domain is a fingerprint 
motif: EQVSHHPP, shared by all members of the ORP family. ORP2 is the only 
member in the family that lacks the N-terminal extension that contains a PH domain. 
In this respect it resembles the yeast OSBP homologues Osh4p-7p. 
We found that ORP2 is ubiquitously expressed in various tissues both at the 
mRNA and the protein level, suggesting a housekeeping-type function. The highest 
expression was found in the nervous tissues, which represent the most cholesterol rich 
tissues in the body. Both the endogenous and the overexpressed protein localize 
mainly to the cytosol of CHO cells, but a fraction is membrane-associated and 
localized to the perinuclear region. Transient overexpression of ORP2 partially 
inhibits the transport of the VSVG protein via the secretory pathway. On the other 
hand, transport of newly synthesized cholesterol to the plasma membrane is enhanced 
in cells stably overexpressing ORP2. Studies performed using stably transfected 
ORP2 overexpressing cells (ORP2/CHO) show that ORP2 has a clear influence on 
cholesterol and phospholipid metabolism in CHO cells. ORP2 decreases cholesterol 
synthesis and esterification, but increases cholesterol efflux. The total cholesterol 
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content in CHO/ORP2 cells was decreased mainly due to a lower amount of 
cholesterol esters. The enhancement of [14C]cholesterol efflux from ORP2/CHO cells 
was only partially inhibited under conditions in which ACAT activity was blocked. 
The lowered cholesterol esterification therefore explains only part of the efflux 
enhancement, suggesting that the effects of ORP2 overexpression on those two 
processes may be independent or due to a different common underlying mechanism. 
The observed increase in transport of newly synthesized cholesterol to the plasma 
membrane indicates that ORP2 overexpression might affect the intracellular 
movement of cholesterol, and by this mechanism enhance the efflux. 
Since cholesterol and phospholipid metabolisms are subject to integrated 
regulation, the synthesis and composition of phospholipids were analyzed. 
Phosphatidylcholine synthesis was markedly enhanced by ORP2 overexpression 
whereas no effects on the synthesis of other phospholipids could be seen. The molar 
ratios of the major phospholipids were unchanged in ORP2/CHO cells. Mass-
spectrometric analysis of the fatty acid composition of phospholipid classes revealed 
an accelerated loss of polyunsaturated phospholipid species in ORP2/CHO after they 
were shifted to lipoprotein deficient medium. This may reflect a change in the 
intracellular transport of phospholipids, leading to enhanced catabolism or increased 
release from the cells. It is also possible that the observed decrease in ACAT activity 
might lead to reduced storage of the polyunsaturated fatty acids in lipid droplets, 
resulting in accelerated turnover. 
  
The data obtained in my thesis work demonstrate the presence of a human 
OSBP-related gene family with 12 members and suggest that ORP2 is a new regulator 
of cellular lipid homeostasis and membrane trafficking.  
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